Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Suzanne E. Dale"'
Autor:
Hayden N. Brochu, Kuncheng Song, Qimin Zhang, Qiandong Zeng, Adib Shafi, Matthew Robinson, Jake Humphrey, Bobbi Croy, Lydia Peavy, Minoli Perera, Scott Parker, John Pruitt, Jason Munroe, Rama Ghatti, Thomas J. Urban, Ayla B. Harris, David Alfego, Brian Norvell, Michael Levandoski, Brian Krueger, Jonathan D. Williams, Deborah Boles, Melinda B. Nye, Suzanne E. Dale, Michael Sapeta, Christos J. Petropoulos, Jonathan Meltzer, Marcia Eisenberg, Oren Cohen, Stanley Letovsky, Lakshmanan K. Iyer
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-15 (2024)
Abstract The COVID-19 pandemic brought forth an urgent need for widespread genomic surveillance for rapid detection and monitoring of emerging SARS-CoV-2 variants. It necessitated design, development, and deployment of a nationwide infrastructure des
Externí odkaz:
https://doaj.org/article/9fe54c9c14ac49e5854ada0811ba5483
Publikováno v:
Frontiers in Public Health, Vol 11 (2023)
ObjectivesThis study aimed to determine the impact of the COVID-19 pandemic on the overall prevalence and co-infection rates for COVID-19, influenza A/B, and respiratory syncytial virus in a large national population.MethodsWe conducted a retrospecti
Externí odkaz:
https://doaj.org/article/d1612394c9464065a56759027dee15a8
Autor:
Victor I. Band, Sarah W. Satola, Richard D. Smith, David A. Hufnagel, Chris Bower, Andrew B. Conley, Lavanya Rishishwar, Suzanne E. Dale, Dwight J. Hardy, Roberto L. Vargas, Ghinwa Dumyati, Marion A. Kainer, Erin C. Phipps, Rebecca Pierce, Lucy E. Wilson, Matthew Sorensen, Erik Nilsson, I. King Jordan, Eileen M. Burd, Monica M. Farley, Jesse T. Jacob, Robert K. Ernst, David S. Weiss
Publikováno v:
mBio, Vol 12, Iss 1 (2021)
Heteroresistance is an underappreciated phenomenon that may be the cause of some unexplained antibiotic treatment failures. Misclassification of heteroresistant isolates as susceptible may lead to inappropriate therapy.
Externí odkaz:
https://doaj.org/article/66ed1c01ff83414ba325c4ef742f6f0e
Autor:
Anita K, Kambhampati, Rachel M, Burke, Stephanie, Dietz, Michael, Sheppard, Olivia, Almendares, Julia M, Baker, Jordan, Cates, Zachary, Stein, Dylan, Johns, Amanda R, Smith, Lara, Bull-Otterson, Megan G, Hofmeister, Stacy, Cobb, Suzanne E, Dale, Karl A, Soetebier, Caelin C, Potts, Jennifer, Adjemian, Aaron, Kite-Powell, Kathleen P, Hartnett, Hannah L, Kirking, David, Sugerman, Umesh D, Parashar, Jacqueline E, Tate
Publikováno v:
MMWR. Morbidity and Mortality Weekly Report. 71:797-802
In November 2021, CDC was notified of a cluster of previously healthy children with hepatitis of unknown etiology evaluated at a single U.S. hospital (1). On April 21, 2022, following an investigation of this cluster and reports of similar cases in E
Autor:
Samantha S. Katz, Damien C. Danavall, Monica R. Morris, Bridgett P. Herrod, Suzanne E. Dale, Melinda B. Nye, Ellen N. Kersh, Robert D. Kirkcaldy, Brian H. Raphael
Publikováno v:
Sex Transm Dis
BACKGROUND: The Aptima Combo 2(®) (AC2) assay manufactured by Hologic, Inc. detects Neisseria gonorrhoeae (NG) and/or Chlamydia trachomatis (CT) in urogenital and extragenital specimens by targeting either a 16S rRNA (NG) or 23S rRNA (CT) region. In
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bf9795e758e81f89e9f9578248cd1e28
https://europepmc.org/articles/PMC9133125/
https://europepmc.org/articles/PMC9133125/
Autor:
Laurent Chesnel, Julia Nary, Adam Cheknis, Susan P Sambol, Richard V. Goering, Stuart Johnson, Dominique Devaris, Suzanne E. Dale, Diane M. Citron
Publikováno v:
Journal of Antimicrobial Chemotherapy. 75:3120-3125
Objectives To investigate the molecular epidemiology and antimicrobial susceptibility of Clostridioides difficile isolates from patients with C. difficile infection (CDI) from two Phase 3 clinical trials of surotomycin. Methods In both trials [Protoc
Autor:
Lavanya Rishishwar, Suzanne E. Dale, Roberto L. Vargas, David S. Weiss, Ghinwa Dumyati, Jesse T. Jacob, Chris Bower, Robert K. Ernst, Eileen M. Burd, Richard D Smith, Marion A. Kainer, Lucy E. Wilson, Andrew B. Conley, I. King Jordan, Erik Nilsson, Sarah W. Satola, Victor I. Band, David A. Hufnagel, Rebecca Pierce, Matthew Sorensen, Dwight J. Hardy, Monica M. Farley, Erin C Phipps
Publikováno v:
mBio, Vol 12, Iss 1 (2021)
mBio
mBio
Heteroresistance is an underappreciated phenomenon that may be the cause of some unexplained antibiotic treatment failures. Misclassification of heteroresistant isolates as susceptible may lead to inappropriate therapy.
Heteroresistance is a for
Heteroresistance is a for
Autor:
Darcie E. Roe-Carpenter, Laurent Chesnel, Julia Nary, Suzanne E. Dale, Diane M. Citron, Christine Hastey, Jennifer H. Law
Publikováno v:
Anaerobe. 44:73-77
Due to increasing antibiotic resistance among anaerobic bacteria, routine antimicrobial susceptibility testing is recommended by the Clinical and Laboratory Standards Institute (CLSI). This study compared the minimum inhibitory concentrations (MICs)
Autor:
Hannah E. Reses, Uzma Ansari, Suzanne E. Dale, Julian E. Grass, Chris Bower, Emily B. Hancock, Daniel Muleta, Nadezhda Duffy, Jesse T. Jacob, Elisabeth Vaeth, Medora Witwer, Joelle Nadle, Ghinwa Dumyati, Isaac See, Zintars G. Beldavs, Joseph D. Lutgring
Publikováno v:
Infection Control & Hospital Epidemiology. 41:s465-s466
Background: Carbapenem-resistant Enterobacteriaceae (CRE) are a major public health problem. Ceftazidime-avibactam (CZA) is a treatment option for CRE approved in 2015; however, it does not have activity against isolates with metallo-β-lactamases (M
Publikováno v:
Antimicrobial Agents and Chemotherapy. 60:2069-2074
Clostridium difficile -associated diarrhea has been associated with disruption of the normal intestinal microbiota, particularly the Bacteroides fragilis group and Prevotella species. Surotomycin is a bactericidal cyclic lipopeptide in development fo